- Home
- PALI vs USNA Comparison
PALI vs USNA Comparison
Compare PALI & USNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PALI | USNA |
|---|---|---|
| Founded | 1996 | 1992 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 359.7M | 397.1M |
| IPO Year | 2019 | 1996 |
Fundamental Metrics
Financial Performance| Metric | PALI | USNA |
|---|---|---|
| Price | $2.03 | $22.87 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $11.29 | N/A |
| AVG Volume (30 Days) | ★ 4.7M | 97.6K |
| Earning Date | 05-11-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 97.06 | N/A |
| EPS | N/A | ★ 0.41 |
| Revenue | $260,000.00 | ★ $1,060,902,000.00 |
| Revenue This Year | N/A | $3.90 |
| Revenue Next Year | N/A | $6.21 |
| P/E Ratio | ★ N/A | $52.28 |
| Revenue Growth | ★ 1500.39 | N/A |
| 52 Week Low | $0.55 | $16.60 |
| 52 Week High | $2.86 | $38.32 |
Technical Indicators
Market Signals| Indicator | PALI | USNA |
|---|---|---|
| Relative Strength Index (RSI) | 54.01 | 63.85 |
| Support Level | $1.57 | $18.71 |
| Resistance Level | $2.16 | $22.64 |
| Average True Range (ATR) | 0.18 | 0.97 |
| MACD | -0.00 | 0.06 |
| Stochastic Oscillator | 47.06 | 86.20 |
Price Performance
Historical ComparisonAbout PALI Palisade Bio Inc.
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.
About USNA USANA Health Sciences Inc.
Usana Health Sciences Inc develops and manufactures high-quality nutritional supplements, functional foods, and personal care products that are sold throughout the world. The company has developed and manufactured high-quality, science-based nutritional, personal care, and skincare products with a primary focus on promoting long-term health and wellness. The Company's reporting units for goodwill purposes are tied to its reportable segments: Core nutritional and Hiya direct-to-consumer. The core nutritional segment consists of three individual reporting units that are determined based on the operational nature of the business: Buy-Sell, China, and India. Geographically, it is in Asia Pacific, the Americas, and Europe. With the majority of revenue from Asia Pacific(Greater China).